Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes

Alejandro Soto-Gutiérrez, Naoya Kobayashi, Jorge David Rivas-Carrillo, Nalu Navarro-Álvarez, Debaio Zhao, Teru Okitsu, Hirofumi Noguchi, Hesham Basma, Yashuhiko Tabata, Yong Chen, Kimiaki Tanaka, Michiki Narushima, Atsushi Miki, Tadayoshi Ueda, Hee Sook Jun, Ji Won Yoon, Jane Lebkowski, Noriaki Tanaka, Ira J. Fox

Research output: Contribution to journalArticle

177 Scopus citations

Abstract

Severe acute liver failure, even when transient, must be treated by transplantation and lifelong immune suppression. Treatment could be improved by bioartificial liver (BAL) support, but this approach is hindered by a shortage of human hepatocytes. To generate an alternative source of cells for BAL support, we differentiated mouse embryonic stem (ES) cells into hepatocytes by coculture with a combination of human liver nonparenchymal cell lines and fibroblast growth factor-2, human activin A and hepatocyte growth factor. Functional hepatocytes were isolated using albumin promoter-based cell sorting. ES cell-derived hepatocytes expressed liver-specific genes, secreted albumin and metabolized ammonia, lidocaine and diazepam. Treatment of 90% hepatectomized mice with a subcutaneously implanted BAL seeded with ES cell-derived hepatocytes or primary hepatocytes improved liver function and prolonged survival, whereas treatment with a BAL seeded with control cells did not. After functioning in the BAL, ES cell-derived hepatocytes developed characteristics nearly identical to those of primary hepatocytes.

Original languageEnglish (US)
Pages (from-to)1412-1419
Number of pages8
JournalNature biotechnology
Volume24
Issue number11
DOIs
StatePublished - Nov 1 2006

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Applied Microbiology and Biotechnology
  • Molecular Medicine
  • Biomedical Engineering

Fingerprint Dive into the research topics of 'Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes'. Together they form a unique fingerprint.

  • Cite this

    Soto-Gutiérrez, A., Kobayashi, N., Rivas-Carrillo, J. D., Navarro-Álvarez, N., Zhao, D., Okitsu, T., Noguchi, H., Basma, H., Tabata, Y., Chen, Y., Tanaka, K., Narushima, M., Miki, A., Ueda, T., Jun, H. S., Yoon, J. W., Lebkowski, J., Tanaka, N., & Fox, I. J. (2006). Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nature biotechnology, 24(11), 1412-1419. https://doi.org/10.1038/nbt1257